B.C. Reg. 101/2025: Amendments to the Drug Schedules Regulation
Made under the Pharmacy Operations and Drug Scheduling Act
How does this rule affect your organization? One Click reads it against your profile and tells you, on Canada Federal Legislative Tracking. See plans →
Get alerted when the next rule lands
New rules land on their own schedule. Pick how you want to hear about them — we email you when one appears.
Publishing to members? Embed a live rule tracker on your own site — the proposed rules in your area and the comment deadlines closing on them, updating themselves. Free, one line of HTML.
The rule, in full
389 words as published, July 15, 2025. View the original →
B.C. Reg. 101/2025, deposited July 3, 2025, under the PHARMACY OPERATIONS AND DRUG SCHEDULING ACT [section 22]. Resolution of the Board of the College of Pharmacists of British Columbia, dated April 25, 2025. The Board of the College of Pharmacists of British Columbia orders that the Drug Schedules Regulation, B.C. Reg. 9/98, is amended as set out in the attached Appendix. — S. SOLVEN, Chair, Board of the College of Pharmacists of British Columbia.
Appendix
1 The Drug Schedules Regulation, B.C. Reg. 9/98, is amended by adding the following sections:
Adoption of national drug lists
4 (1) In this section: "National Drug Schedules" means the National Drug Schedules produced by the National Association of Pharmacy Regulatory Authorities; "Prescription Drug List" has the meaning given to it in section A.01.010 of the Food and Drug Regulations, C.R.C., c. 870. (2) Subject to section 5, the National Drug Schedules and the Prescription Drug List are adopted as follows: (a) drugs that are listed in the Prescription Drug List or Schedule I of the National Drug Schedules are, if not listed in a Schedule to this regulation, deemed to be listed in Schedule I of this regulation; (b) drugs that are listed in Schedule II of the National Drug Schedules are, if not listed in a Schedule to this regulation, deemed to be listed in Schedule II of this regulation; (c) drugs that are listed in Schedule III of the National Drug Schedules are, if not listed in a Schedule to this regulation, deemed to be listed in Schedule III of this regulation. (3) For the purposes of section 22 (3) and (4) of the Pharmacy Operations and Drug Scheduling Act, (a) the National Association of Pharmacy Regulatory Authorities is a body approved by the board, and (b) the Prescription Drug List and the National Drug Schedules are adopted as amended from time to time.
Exception
5 Section 4 (2) does not apply to a drug listed in the table below. Excepted Drugs Antiprogestins including but not limited to mifepristone and its derivatives Ephedrine and its salts Naloxone and its salts Nicotine and its salts for human use Prostaglandins and their salts and derivatives or analogues including but not limited to misoprostol Pseudoephedrine and its salts Semaglutide Sex hormones (natural or synthetic) including but not limited to levonorgestrel Vaccines
Documents
- The text in The British Columbia Gazette · July 15, 2025